De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
| Autor: | Guarneri, V. *, Dieci, M.V., Bisagni, G., Frassoldati, A., Bianchi, G.V., De Salvo, G.L., Orvieto, E., Urso, L., Pascual, T., Paré, L., Galván, P., Ambroggi, M., Giorgi, C.A., Moretti, G., Griguolo, G., Vicini, R., Prat, A., Conte, P.F. |
|---|---|
| Zdroj: | In Annals of Oncology June 2019 30(6):921-926 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|